drugset / Trial / NCT02715960

Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules

NCT02715960

Phase 2 Unknown 500 enrolled Central South University
NaSingle-groupOpen-labelTreatment

Summary

In an early clinical research, 138 patients completed the treatment of Psoriasis Vulgaris by Acitretin Capsules in 8 weeks, the results indicate 75 cases effectively (54.3%), 50 cases invalid(36.2%), 13 cases serious(9.4%). To investigate the influence of genetic factors on the curative effect and find the relationships between genetic variants and the response of Acitretin Capsules to treatment of Psoriasis Vulgaris.

Timeline

Start
2015-12
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 30 mg Oral

Indications